Meeting Banner
Abstract #1237

Vessel Density Imaging in Normal Human Brain Using Ferumoxytol

Helen Erica D'Arceuil1, Alex de Crespigny2, Michael E. Moseley3, Francis Blankenberg4, Maarten Lansberg5

1Diagnostic Radiology, Stanford, Stanford, CA, United States; 2Genentech Inc, South San Francisco, CA, United States; 3Diagnostic Radiology, Stanford University, Stanford, CA, United States; 4Pediatric Radiology, Stanford Hospital and Clinics, Palo Alto, CA, United States; 5Neurology and Neurological Sciences, Stanford Stroke Center, Stanford Hospital and Clinics, Stanford, CA, United States


We estimated the vessel density parameter Q from changes in R2 and R2* relaxation rates before/after injection of ferumoxytol in 5 healthy subjects. Changes in R2 were highly correlated with changes in R2*. Q in normal gray matter was about 0.58, comparable to that previously reported in rodent brain, using MION contrast agents. This approach using a contrast agent at steady-state permits high resolution imaging of vascular parameters and may prove useful for assessment of angiogenesis, for example during vascular targeted therapy in oncology or regenerative therapy in stroke.

Keywords

agentcontrastpostvesseldensitydynamicinjectionmapsbolusgrayhumansmeasuredradiologystrokesusceptibilitywhitebrainclinicsclosecorpuscorticaldiagnostichospitalhumanresolutiontissueadvantageaimedallowsaltoanemiaapprovalapprovedassessingassessmentbackgroundbeckbloodboardcancercellcityconcentrationconsentconsistentlycontainingcorrelationcortexderiveddifferentialdiffusiondiscoverydistortionsdistributiondosedrivendualenablesenrolledestimationexamplefeasiblefivefrontalhalfhealthyimplementedimportantin vivoinformedironlikelylocalmademetricmodernneurological